113 related articles for article (PubMed ID: 12177731)
21. Clinical significance of mrp gene in primary hepatocellular carcinoma.
Wang BL; Chen XP; Zhai SP; Chen DF
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):397-403. PubMed ID: 14599947
[TBL] [Abstract][Full Text] [Related]
22. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer with P-glycoprotein expression.
Yeh JJ; Hsu WH; Wang JJ; Ho ST; Kao A
Respiration; 2003; 70(1):32-5. PubMed ID: 12584388
[TBL] [Abstract][Full Text] [Related]
23. Expression of multidrug resistance-1 and multidrug resistance-associated protein genes in pediatric rhabdomyosarcoma.
Gallego S; Llort A; Parareda A; Sanchez De Toledo J
Oncol Rep; 2004 Jan; 11(1):179-83. PubMed ID: 14654923
[TBL] [Abstract][Full Text] [Related]
24. Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteins.
Eid H; Géczi L; Mágori A; Bodrogi I; Institoris E; Bak M
Anticancer Res; 1998; 18(4C):3059-64. PubMed ID: 9713510
[TBL] [Abstract][Full Text] [Related]
25. [Expression of lung resistance protein and multidrug resistance-associated protein in naive childhood acute leukemia and their clinical significance].
Zhang JB; Sun Y; Dong J; Liu LX; Ning F
Ai Zheng; 2005 Aug; 24(8):1015-7. PubMed ID: 16086885
[TBL] [Abstract][Full Text] [Related]
26. Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.
Oshita F; Ikehara M; Sekiyama A; Hamanaka N; Saito H; Yamada K; Noda K; Kameda Y; Miyagi Y
J Exp Ther Oncol; 2004 Jul; 4(2):155-60. PubMed ID: 15500010
[TBL] [Abstract][Full Text] [Related]
27. [Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer].
Paredes Lario A; Blanco García C; Echenique Elizondo M; Lobo C
Arch Bronconeumol; 2007 Sep; 43(9):479-84. PubMed ID: 17919413
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
[TBL] [Abstract][Full Text] [Related]
29. [Expression and implication of Pgp, MRP, LRP, GST-pi, Topo II alpha in tongue squamous cell carcinoma].
Leng WD; Wang DZ; Feng G; He J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Feb; 22(1):23-5. PubMed ID: 15017692
[TBL] [Abstract][Full Text] [Related]
30. MRP- and BCL-2-mediated drug resistance in human SCLC: effects of apoptotic sphingolipids in vitro.
Khodadadian M; Leroux ME; Auzenne E; Ghosh SC; Farquhar D; Evans R; Spohn W; Zou Y; Klostergaard J
Lung Cancer; 2009 Oct; 66(1):48-57. PubMed ID: 19195736
[TBL] [Abstract][Full Text] [Related]
31. [Expression of multidrug resistance-associated protein (MRP) and lung resistance protein (LRP) in human rectal carcinomas and its clinical significance].
Peng X; Feng F; Zhang W
Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):193-5. PubMed ID: 11776833
[TBL] [Abstract][Full Text] [Related]
32. Ependymomas in children express the multidrug resistance gene: immunohistochemical and molecular biologic study.
Chou PM; Barquin N; Gonzalez-Crussi F; Ridaura Sanz C; Tomita T; Reyes-Mugica M
Pediatr Pathol Lab Med; 1996; 16(4):551-61. PubMed ID: 9025853
[TBL] [Abstract][Full Text] [Related]
33. Technetium-99m tetrofosmin SPECT predicts chemotherapy response in small cell lung cancer.
Yeh JJ; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
Tumour Biol; 2003; 24(3):151-5. PubMed ID: 14610319
[TBL] [Abstract][Full Text] [Related]
34. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
35. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliën JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of MRP2 and clinical resistance to platinum-based chemotherapy in small cell lung cancer.
Ushijima R; Takayama K; Izumi M; Harada T; Horiuchi Y; Uchino J; Hara N; Nakanishi Y
Anticancer Res; 2007; 27(6C):4351-8. PubMed ID: 18214043
[TBL] [Abstract][Full Text] [Related]
37. Determination and prediction of P-glycoprotein and multidrug-resistance-related protein expression in breast cancer with double-phase technetium-99m sestamibi scintimammography. Visual and quantitative analyses.
Kim IJ; Bae YT; Kim SJ; Kim YK; Kim DS; Lee JS
Oncology; 2006; 70(6):403-10. PubMed ID: 17237619
[TBL] [Abstract][Full Text] [Related]
38. To predict chemotherapy response using technetium-99m tetrofosmin and compare with p-glycoprotein and multidrug resistance related protein-1 expression in patients with untreated small cell lung cancer.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Cancer Lett; 2001 Aug; 169(2):181-8. PubMed ID: 11431107
[TBL] [Abstract][Full Text] [Related]
39. [Relationships among expressions of hTERT, MDR1, MRP mRNA, and C-myc protein in non-small cell lung cancer].
Li L; Xiong YY; Liu L; Chen TX; Yao XF; Wang YW
Ai Zheng; 2005 Jan; 24(1):53-7. PubMed ID: 15642200
[TBL] [Abstract][Full Text] [Related]
40. Technetium-99m tetrofosmin chest imaging related to p-glycoprotein expression for predicting the response with paclitaxel-based chemotherapy for non-small cell lung cancer.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Lung; 2001; 179(4):197-207. PubMed ID: 11891611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]